Concepedia

Hootan Khatami

HK

Statistics

Publications

4

Citations

1.3K

H-Index

4

Active since

2006

Affiliations

San Francisco General Hospital(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

University of California, San Francisco

Hootan Khatami is an author at San Francisco General Hospital specializing in medicine, cardiovascular disease, and diabetes.

Top concepts

Publications per year

2006–2009

4

Publications

4

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy in patients with type 2 diabetes mellitus

Itamar Raz, M Hanefeld, Lei Xu et al. · Diabetologia · 2006 · 614 citations · Full text

, , +5

Efficacy and safety of the dipeptidyl peptidase‐4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin

Kjeld Hermansen, Mark Kipnes, Edmund Luo et al. · Diabetes Obesity and Metabolism · 2007 · 522 citations · Full text

The Effects of Recombinant Human Leptin on Visceral Fat, Dyslipidemia, and Insulin Resistance in Patients with Human Immunodeficiency Virus-Associated Lipoatrophy and Hypoleptinemia

Kathleen Mulligan, Hootan Khatami, Jean‐Marc Schwarz et al. · The Journal of Clinical Endocrinology & Metabolism · 2009 · 127 citations · Full text

Creatine Fails to Augment the Benefits from Resistance Training in Patients with HIV Infection: A Randomized, Double-Blind, Placebo-Controlled Study

Giorgos K. Sakkas, Kathleen Mulligan, Makani DaSilva et al. · PLoS ONE · 2009 · 45 citations · Full text

1–4 of 4